Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04641078
Title Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer (DART)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Ghent
Indications

prostate adenocarcinoma

Therapies

Darolutamide

Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.